Upcoming Mesothelioma Symposium Filled with Hope

Treatment & Doctors
Reading Time: 3 mins
Publication Date: 08/29/2017
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us


"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating

How to Cite Asbestos.com’s Article


Povtak, T. (2020, October 16). Upcoming Mesothelioma Symposium Filled with Hope. Asbestos.com. Retrieved December 9, 2022, from https://www.asbestos.com/news/2017/08/29/mesothelioma-symposium-ucla/


Povtak, Tim. "Upcoming Mesothelioma Symposium Filled with Hope." Asbestos.com, 16 Oct 2020, https://www.asbestos.com/news/2017/08/29/mesothelioma-symposium-ucla/.


Povtak, Tim. "Upcoming Mesothelioma Symposium Filled with Hope." Asbestos.com. Last modified October 16, 2020. https://www.asbestos.com/news/2017/08/29/mesothelioma-symposium-ucla/.

Thoracic surgeon Dr. Robert Cameron remembers well — it wasn’t that long ago — when a diagnosis of pleural mesothelioma cancer automatically came with a gloom-and-doom tone.

Those days are gone.

His 7th annual International Symposium on Mesothelioma at UCLA on Sept. 30 will accentuate the substantial recent progress.

“Over the past five years, we’ve seen unprecedented advances in mesothelioma research that we never would have predicted a decade ago,” said Cameron, chief of thoracic surgery at the West Los Angeles VA Medical Center. “And our intensive collaboration today between laboratory and clinical scientists is yielding new insight into promising future treatment.”

Cameron, a pioneer in mesothelioma surgical treatment, will serve as the symposium chair of the upcoming event, which presents medical professionals, patients and families an opportunity to learn more about the latest advances and the hope that has emerged.

Mesothelioma Experts from Around the World

Cameron, who is also director of the UCLA Mesothelioma Comprehensive Research Program, will be one of several experts speaking at the daylong event.

The lineup of mesothelioma experts and topics includes:

  • Robert Cameron: “Surgery for Mesothelioma: Is There a Future?”
  • Clinical professor Dr. Olga Olevsky of the UCLA School of Medicine: “Intracavitary Therapeutics for Pleural Mesothelioma.”
  • Thoracic surgeon Dr. Jacques Fontaine of the Moffitt Cancer Center: “Transarterial Chemoperfusion.”
  • Luana Calabro of Italy’s Center at the University Hospital of Siena: “Immune Checkpoint Blockade in Malignant Mesothelioma.”
  • Medical oncologist Dr. Anna Nowak of the University of Western Australia: “Combining Angiogenesis Inhibition with Chemotherapy — Who, How and What’s Next?”
  • Hanning Yang of the University of Hawaii Cancer Cancer: “Mesothelioma and BAP1.”
  • Pathologist Dr. Brian Cunniff of the University of Vermont College of Medicine: “The Potato in the Tailpipe. Disabling Mitochondrial Peroxide Metabolism as an Effective Therapeutic Approach.”
  • Senior investigator Dr. David Schrump of the National Cancer Institute: “Targeting the Epigenome in Malignant Pleural Mesothelioma.”
  • Biochemist Arti Shukia of India’s Banaras Hindu University: “Inflammasome Modulation by Chemotherapeutics in Mesothelioma: Is This a Possibility?”

Discussions About Immunotherapy for Mesothelioma

Cameron also will speak about engineering mesenchymal stem cells for immunotherapy.

Clare Cameron, who is the executive director of the Pacific Mesothelioma Center (PMC) and not related to Dr. Robert Cameron, will talk about resources for research. Lein Hua-Feng, a nurse practitioner at PMC, will discuss the benefits of caregiver support groups.

“The symposium will provide an unrivaled opportunity for both the medically savvy and general public, including mesothelioma patients,” Clare Cameron said. “You’ll hear about the most promising medical advances, and promising new research.”

The symposium arrives on the heels of an anonymous $1 million donation to the PMC, where Dr. Cameron serves as scientific advisor.

The grant will be used to support a molecular biologist and an immunologist working on potential immunotherapies for mesothelioma.

Immunotherapy, which has shown effectiveness in other cancers, involves enhancing a patient’s own immune system to fight off the cancer cells. The treatment, which isn’t approved by the U.S. Food and Drug Administration for mesothelioma, is available only through clinical trials and with special access exceptions.

Cameron believes, though, that future treatment advances will involve a combination of different emerging immunotherapies, along with traditional treatment such as surgery and chemotherapy.

“For the first time ever, we are seeing real benefits of immunotherapy for mesothelioma,” he said. “I believe it holds great promise for finally improving the survival of patients with this formally fatal disease.”

Medically Reviewed by Top Mesothelioma Doctors
Free Mesothelioma Guide